Literature DB >> 12892529

Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors.

Robert L Ochs1, Jeffrey Fensterer, N Paul Ohori, Alan Wells, Michael Gabrin, Lisa D George, Paul Kornblith.   

Abstract

Isolation and growth of malignant cells from solid tumors have often met with disappointing results. Consequently, we have developed a cell culture methodology based on ex vivo explantation of tumor tissue, with subsequent monolayer cell outgrowth. In an attempt to assess methods for detection of malignant cells in these cultures, we analyzed and compared the results of cytopathology, growth in soft agar, and detection of telomerase activity with those of standard immunohistochemistry (IHC) techniques for the detection of cytokeratins, tumor marker p53, and proliferation marker Ki-67. The sensitivity of detection of malignant cells was 85% (22/26) for cytopathological examination, 30% (3/10) for soft agar growth, and 100% (12/12) for detection of telomerase activity. From these data, we concluded that both cytopathological examination and assessment of telomerase activity contribute to the detection of malignant cells in primary cultures of human solid tumors, whereas growth in soft agar was not a good indicator of malignant cells. Although not specific for malignant cells per se, IHC detection for epithelial cell cytokeratins showed a high degree of sensitivity (100%, 23/23), whereas the sensitivity for detection of tumor marker p53 and proliferation marker Ki-67 was 30% (7/23) and 70% (16/23), respectively. These data also provide proof that malignant tumor cells, derived from a diverse number of human solid tumors, can be isolated and grown in primary cell culture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892529     DOI: 10.1290/1543-706X(2003)039<0063:EFTIGA>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  27 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Regulation of telomerase activity in immortal cell lines.

Authors:  S E Holt; W E Wright; J W Shay
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

3.  Assessment of methods for primary tissue culture of human breast epithelia.

Authors:  M V Croce; A G Colussi; A Segal-Eiras
Journal:  J Exp Clin Cancer Res       Date:  1998-03

4.  Novel fibroblast-specific monoclonal antibodies: properties and specificities.

Authors:  A Saalbach; U Aneregg; M Bruns; E Schnabel; K Herrmann; U F Haustein
Journal:  J Invest Dermatol       Date:  1996-06       Impact factor: 8.551

5.  Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells.

Authors:  S H Dairkee; E C Paulo; P Traquina; D H Moore; B M Ljung; H S Smith
Journal:  Cancer Res       Date:  1997-04-15       Impact factor: 12.701

6.  Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.

Authors:  M Brower; D N Carney; H K Oie; A F Gazdar; J D Minna
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

7.  Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.

Authors:  J Bártek; J Bártková; B Vojtĕsek; Z Stasková; J Lukás; A Rejthar; J Kovarík; C A Midgley; J V Gannon; D P Lane
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

Review 8.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.

Authors:  S P Ethier; M L Mahacek; W J Gullick; T S Frank; B L Weber
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

10.  Short-term primary culture of epithelial cells derived from human breast tumours.

Authors:  V Speirs; A R Green; D S Walton; M J Kerin; J N Fox; P J Carleton; S B Desai; S L Atkin
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more
  9 in total

1.  Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer.

Authors:  Jumpei Kondo; Hiroko Endo; Hiroaki Okuyama; Osamu Ishikawa; Hiroyasu Iishi; Masahiko Tsujii; Masayuki Ohue; Masahiro Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

2.  Feasibility assessment of in vitro chemoresponse assay on stereotactic biopsies of glioblastoma multiforms: a step towards personalized medicine.

Authors:  Fariba Sadeghi Fazel; Mahnaz Haddadi; Alireza Khoshnevisan; Samad Muhammadnejad; Ahad Muhammadnejad; Zohreh Mazaheri; Motahareh Arjomandnejad; Reza Shirkoohi; Mohammad-Ali Oghabian; Narjes Sherkat-Khameneh; Saeid Amanpour; Monireh Kazemimanesh
Journal:  Iran J Basic Med Sci       Date:  2014-11       Impact factor: 2.699

3.  Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.

Authors:  Yvonne L Chao; Christopher R Shepard; Alan Wells
Journal:  Mol Cancer       Date:  2010-07-07       Impact factor: 27.401

4.  Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues.

Authors:  Ingrid Cifola; Cristina Bianchi; Eleonora Mangano; Silvia Bombelli; Fabio Frascati; Ester Fasoli; Stefano Ferrero; Vitalba Di Stefano; Maria A Zipeto; Fulvio Magni; Stefano Signorini; Cristina Battaglia; Roberto A Perego
Journal:  BMC Cancer       Date:  2011-06-13       Impact factor: 4.430

5.  Novel Phenotypic Fluorescent Three-Dimensional Co-Culture Platforms for Recapitulating Tumor in vivo Progression and for Personalized Therapy.

Authors:  Changge Fang; Yan-Gao Man; Frank Cuttitta; William Stetler-Stevenson; David Salomon; Andrew Mazar; Piotr Kulesza; Steve Rosen; Itzhak Avital; Alexander Stojadinovic; Anahid Jewett; Bin Jiang; James Mulshine
Journal:  J Cancer       Date:  2013-12-01       Impact factor: 4.207

Review 6.  Challenges of applying multicellular tumor spheroids in preclinical phase.

Authors:  Se Jik Han; Sangwoo Kwon; Kyung Sook Kim
Journal:  Cancer Cell Int       Date:  2021-03-04       Impact factor: 5.722

7.  Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies.

Authors:  Ralf Hass; Catharina Bertram
Journal:  J Exp Clin Cancer Res       Date:  2009-09-14

8.  Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine.

Authors:  Nazleen C Lobo; Craig Gedye; Anthony J Apostoli; Kevin R Brown; Joshua Paterson; Natalie Stickle; Michael Robinette; Neil Fleshner; Robert J Hamilton; Girish Kulkarni; Alexandre Zlotta; Andrew Evans; Antonio Finelli; Jason Moffat; Michael A S Jewett; Laurie Ailles
Journal:  BMC Cancer       Date:  2016-07-16       Impact factor: 4.430

Review 9.  Hydrogel microenvironments for cancer spheroid growth and drug screening.

Authors:  Yunfeng Li; Eugenia Kumacheva
Journal:  Sci Adv       Date:  2018-04-27       Impact factor: 14.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.